Market open
Beta Bionics, Inc./$BBNX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Beta Bionics, Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Ticker
$BBNX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
293
Website
BBNX Metrics
BasicAdvanced
$467M
-
-$8.60
-
-
Price and volume
Market cap
$467M
52-week high
$21.62
52-week low
$10.63
Financial strength
Current ratio
6.285
Quick ratio
5.465
Long term debt to equity
7.533
Total debt to equity
9.544
Management effectiveness
Return on assets (TTM)
-21.78%
Return on equity (TTM)
-81.35%
Valuation
Price to revenue (TTM)
1.053
Price to book
-0.29
Price to tangible book (TTM)
-0.29
Price to free cash flow (TTM)
-1.327
Growth
Revenue change (TTM)
442.93%
Earnings per share change (TTM)
3.46%
BBNX News
AllArticlesVideos
Beta Bionics Announces Board Appointment of Gerard Michel
GlobeNewsWire·1 week ago
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
GlobeNewsWire·1 week ago
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Beta Bionics, Inc. stock?
Beta Bionics, Inc. (BBNX) has a market cap of $467M as of April 04, 2025.
What is the P/E ratio for Beta Bionics, Inc. stock?
The price to earnings (P/E) ratio for Beta Bionics, Inc. (BBNX) stock is 0 as of April 04, 2025.
Does Beta Bionics, Inc. stock pay dividends?
No, Beta Bionics, Inc. (BBNX) stock does not pay dividends to its shareholders as of April 04, 2025.
When is the next Beta Bionics, Inc. dividend payment date?
Beta Bionics, Inc. (BBNX) stock does not pay dividends to its shareholders.
What is the beta indicator for Beta Bionics, Inc.?
Beta Bionics, Inc. (BBNX) does not currently have a Beta indicator.